Key recent developments in the United Kingdom and Europe
relating to patents and the pharmaceutical sector
In this
issue we report on the Supreme Court decision of Shanks v
Unilever on employee inventor compensation. We update on two
CJEU decisions relation to public access to documents submitted to
the EMA and a key competition decision on "pay-for-delay"
agreements. We cover a string of patent-related UK Court of Appeal
cases, including Ablynx v VHSquared on jurisdiction,
Anan Kasei v Neo on insufficiency and joint tortfeasorship
and L'Oreal v Liqwd on claim amendments and admission
of late evidence. We provide brief updates from the EPO on the
recent CRISPR priority decision, as well as its AI inventorship
decision. We have bumper SPC and FRAND updates covering key Court
of Appeal and CJEU decisions in respect of SPCs and a string of
interesting interim decisions in the UK in the case of FRAND. We
round off the issue with a link to our new IP podcast series
